BACKGROUND: Tumor-derived proprotein convertase subtilisin/kexin type 9 (PCSK9) facilitates tumor progression, but the role of immune cell-intrinsic PCSK9 in tumor control remains unclear. METHODS: Orthotopic models of pancreatic cancer and melanoma in Pcsk9-deficient mice were established and tumor-infiltrating immune cells were analyzed using single-cell RNA sequencing and flow cytometry. The effect of genetic disruptions of PCSK9 on murine CD8(+) T cells and human chimeric antigen receptor (CAR)-T cells was evaluated both in vitro and in vivo. RESULTS: Ablation of host Pcsk9 remarkably suppressed tumor growth and prolonged the survival of tumor-bearing mice, while tumor cells still express PCSK9. The enhanced tumor suppression in Pcsk9-deficient mice depended on CD8(+) T cells. Notably, PCSK9 expression was induced in CD8(+) tumor-infiltrating lymphocytes (TILs). Consequently, Pcsk9 ablation potentiated the antitumor capacity of CD8(+) T cells, showing increased intratumoral infiltration and improved cytotoxic function, along with higher proportions of both effector-memory precursor exhausted (T(PEX)) and terminally exhausted (T(TEX)) CD8(+) TILs. Additionally, disruption of PCSK9 in both murine CD8(+) T cells and human CAR-T cells, synergistic with PD-1 blockade, promoted tumor suppression. CONCLUSION: These findings indicate that PCSK9 inhibits the antitumor function of CD8(+) T cells, suggesting it may be a promising target for enhancing T-cell-based cancer immunotherapy.
Disruption of cell-intrinsic PCSK9 enhances the antitumor efficacy of CD8(+) T cells.
阅读:4
作者:Liu Bing, Cai Letong, Yan Yiwen, Mao Chengzhou, Zhang Xiaohui, He Yudan, Chen Si, Liu Lizhong, Xu Zhe, Xu Long, Wang FuSheng, Yu Li, Danser A H Jan, Lu Xifeng, Xing Shaojun
期刊: | Journal for ImmunoTherapy of Cancer | 影响因子: | 10.600 |
时间: | 2025 | 起止号: | 2025 Jul 15; 13(7):e011657 |
doi: | 10.1136/jitc-2025-011657 |
特别声明
1、本文转载旨在传播信息,不代表本网站观点,亦不对其内容的真实性承担责任。
2、其他媒体、网站或个人若从本网站转载使用,必须保留本网站注明的“来源”,并自行承担包括版权在内的相关法律责任。
3、如作者不希望本文被转载,或需洽谈转载稿费等事宜,请及时与本网站联系。
4、此外,如需投稿,也可通过邮箱info@biocloudy.com与我们取得联系。